Developer docs
API playgroundTry for free, no card

Search company profiles

Everglade Consulting

Full company profile

uuid0000m2o

Namestring
Everglade Consulting
Legal namestring
EverGlade Consulting, LLC
Websiteurl
everglade.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Everglade Consulting (legal entity: EverGlade Consulting, LLC) is a privately held, U.S.-headquartered advisory firm that helps life sciences and technology innovators navigate the federal funding ecosystem from opportunity identification through post-award program closeout. Founded in 2020 and operating from Houston, TX and Washington, DC, the firm is organized around a four-stage lifecycle — Strategize, Propose, Negotiate, Execute — delivered through dedicated practices across HHS (BARDA, ARPA-H, NIAID, ASPR IBx), DoD (DARPA, DTRA, DIU, JPEO-CBRND consortium vehicles MTEC, MCDC, CWMD), civilian energy agencies (DOE Loan Programs Office, ARPA-E, EERE), and the International Development Finance Corporation. The firm has stated it has helped clients secure more than $3 billion in non-dilutive federal funding across agencies, with named engagements including up to $45M for GeoVax Labs (BARDA, 2024) and up to $18.3M for Landmark Bio (ARPA-H, 2026).

The firm's underlying capability stack rests on regulatory fluency in FAR, DFARS, CAS, and federal acquisition mechanisms (BAAs, RFPs, OTAs, cooperative agreements), combined with a senior bench of PhD scientists, PMP-certified program managers, MBAs, and former government COTRs/Auditors. Its proprietary program infrastructure comprises standardized tools, templates, and processes built through repeated R&D program execution, packaged into a repeatable methodology marketed as "Boost Your Success Rate." Distribution is sales-led and direct: the firm runs a content-marketing engine (blog, solicitation alerts, LinkedIn, YouTube, PR Newswire distributions) feeding direct enterprise consultations with biotech, medtech, pharma, autonomous tech, AI/cybersecurity, energy, and academic research clients.

Everglade is bootstrapped and founder-owned (co-founders Eric Jia-Sobota and Jerry Jia-Sobota), with no disclosed venture or private equity rounds. Giacomo Apadula, Jr. was appointed CEO effective October 6, 2025, and Dr. Patrick Sims joined as Managing Consultant in April 2026, signaling a transition from founder-led to professionally-managed scale-up. Revenue is generated through customized, quote-based professional services engagements, typically structured as multi-year contracts tied to pursuit-and-execution milestones.

Short descriptiontext

EverGlade Consulting is a privately held U.S. advisory firm that helps life sciences and technology innovators secure and execute non-dilutive federal funding across HHS, DoD, civilian science agencies, DOE, and DFC, offering a full Strategize-to-Execute lifecycle service.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
federal funding advisory, life sciences consulting, government grant services, technology funding consulting, proposal development services
Industry2 codes
PRIMARYBPAHACAJ
Risk, Compliance & Internal Controls Consulting
SECONDARYBPAHACAM
Innovation, Product & R&D Consulting
NAICS code2 codes
  • Management Consulting Services54161
  • Management, Scientific, and Technical Consulting Services5416
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Federal Funding Advisory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Federal Funding Advisory Services
TypeProfessional Services
Description

Professional consulting services for the full federal funding lifecycle including strategy, proposal pursuit, contract negotiations, and post-award execution and compliance support. Services are tailored to each client engagement with custom pricing based on scope and complexity.

everglade.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Custom consulting engagements
ModelOtherBilling cadenceMulti-year contract
Notes

No standard pricing tiers disclosed. Services are quote-based and tailored to each client's specific federal funding needs and engagement scope.

everglade.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Everglade Consulting provides professional advisory services that guide life sciences and technology innovators through the full federal funding lifecycle, including strategy, proposal pursuit, contract negotiations, and post-award execution and compliance support. The firm secures and executes high-risk, high-impact R&D funding programs across HHS, DoD, and civilian science and technology agencies. Service offerings are organized as Strategize, Propose, Negotiate, and Execute, with specialized advisory for agencies such as BARDA, ARPA-H, NIAID, DARPA, DTRA, DIU, DOE, and DFC.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • $3B+ in non-dilutive federal funding secured across agencies
+2 more records
Product overview1 text field

Everglade Consulting is a national advisory firm that provides strategic consulting services to help life sciences and technology innovators navigate the federal funding ecosystem. The company offers a comprehensive suite of advisory services organized around the federal funding lifecycle: Strategize, Propose, Negotiate, and Execute. Their service offerings are specialized by funding domain, including BARDA Funding Advisory, ARPA-H Funding Advisory, NIAID Funding Advisory, CPE CBRND Funding Advisory, DoD Agencies & Offices Advisory, Autonomous Technology Funding Advisory, Energy Funding Advisory, and DFC Loan Advisory. The firm supports clients across HHS, DoD, and civilian science and technology agencies, helping secure non-dilutive funding for high-risk, high-impact R&D programs.

Product and service12 records
1Strategize Services
CategoryAdvisory Service
Description

Federal funding pursuit strategy development including program fit validation, technical viability assessment, technology alignment to agency priorities, and ongoing federal landscape review, for organizations seeking non-dilutive R&D funding.

2Propose Services
CategoryAdvisory Service
Description

Proposal development and submission support including TechWatch meetings, concept papers, white papers, solution summaries, full proposal development, statement of work, work breakdown structure, technical approach, integrated master schedule, budget design, and subcontractor management, for clients pursuing federal funding.

3Negotiate Services
CategoryAdvisory Service
Description

Contract negotiation support including contract review and positioning, cost share and budget clarifications, response strategy development, and terms alignment and finalization, for clients negotiating federal awards.

4Execute Services
CategoryAdvisory Service
Description

Post-award program execution support including program oversight, risk and performance management, subcontractor and procurement oversight, financial and contract compliance with USG audit support, and project closeout, for clients executing federal awards.

5BARDA Funding Advisory
CategoryAdvisory Service
Description

Specialized advisory services for securing funding from the Biomedical Advanced Research and Development Authority (BARDA), supporting vaccine, therapeutic, and diagnostic development through BAAs, RFPs, and Other Transaction Agreements, for biotech and life sciences companies.

6ARPA-H Funding Advisory
CategoryAdvisory Service
Description

Advisory services for securing funding from the Advanced Research Projects Agency for Health (ARPA-H), including support for Innovative Solutions Openings (ISOs), Mission Office ISOs, and targeted research initiatives, for health-focused research organizations.

7NIAID Funding Advisory
CategoryAdvisory Service
Description

Advisory services for securing funding from the National Institute of Allergy and Infectious Diseases (NIAID), including grants, contracts, and cooperative agreements for infectious and immunologic disease research, for academic and biotech clients.

8JPEO CBRND Funding Advisory
CategoryAdvisory Service
Description

Advisory services for Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense funding opportunities, including MTEC, MCDC, and CWMD consortium programs, for biodefense and CBRN defense clients.

9DoD Agencies & Offices Funding Advisory
CategoryAdvisory Service
Description

Advisory services for Department of Defense funding including DARPA (synthetic biology, trauma care, biosciences), DTRA (biodefense technologies), DPA Title III (domestic production capabilities), and DIU (commercial technology adoption), for defense-oriented biotech and technology clients.

10Autonomous Technology Funding Advisory
CategoryAdvisory Service
Description

Advisory services for autonomous technology and AI funding including defense and security innovation (DARPA, DIU, JAIC), artificial intelligence R&D (NSF AI Institutes, DOE AI Grants), emerging technologies, cybersecurity, and unmanned systems, for AI, cybersecurity, and autonomous systems companies.

11Energy Funding Advisory
CategoryAdvisory Service
Description

Advisory services for energy innovation funding including DOE Loan Programs Office support, ARPA-E (energy technology RDT&E), EERE (energy efficiency and renewable energy), and Infrastructure Investment and Jobs Act programs, for clean energy and sustainable technology organizations.

12DFC Loan Advisory
CategoryAdvisory Service
Description

Advisory services for International Development Finance Corporation (DFC) loan programs supporting private sector investment in emerging markets, including healthcare, biotechnology, technology, advanced manufacturing, defense, infrastructure, and renewable energy sectors, for companies pursuing international expansion financing.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-21
Description

Everglade guided Landmark Bio through the federal funding process including negotiations, project structuring, and financial planning to secure up to $18.3 million from ARPA-H's TRANSFORM-EV program for extracellular vesicle manufacturing.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-28
Description

Everglade supported GeoVax Labs in securing up to $45 million in BARDA funding for next-generation COVID-19 vaccine development. The partnership included manufacturing support and Phase 2b clinical trial funding.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Everglade manages technical and financial reporting processes for IDBiologics' federal award, allowing the client to focus on scientific research and discovery.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Supporting partner in GeoVax COVID-19 vaccine development with overall clinical evaluation value up to $388 million including additional support from Allucent.

Strategic tierMinorTypeOthers
Description

Everglade supports clients pursuing funding through MTEC, which focuses on accelerating development of medical technologies for military and civilian use in support of DTRA.

6Rapid Response Partnership Vehicle (RRPV) Consortium
Strategic tierMinorTypeOthers
Description

Joint initiative with BARDA to promote R&D in response to pandemics or public health emergencies. Everglade helps clients access funding through this consortium vehicle.

everglade.com
7Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C)
Strategic tierMinorTypeOthers
Description

Consortium advancing biomanufacturing innovations to enhance production efficiency and scalability, with Everglade supporting client participation.

everglade.com
8Medical CBRN Defense Consortium (MCDC)
Strategic tierMinorTypeOthers
Description

Consortium advancing development efforts to support DoD's medical, pharmaceutical, and diagnostic requirements related to CBRN defense.

everglade.com
9Countering Weapons of Mass Destruction Consortium (CWMD)
Strategic tierMinorTypeOthers
Description

Consortium supporting DoD's ability to detect, prevent, and protect against WMD threats, with Everglade assisting client engagement.

everglade.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1The Conafay Group
TypeDirect peer
Description

Life sciences-focused federal funding and SBIR/STTR advisory firm supporting biotech and medtech companies pursuing BARDA, NIH, and DoD awards. Direct head-to-head competitor in the federal grant advisory niche Everglade serves.

TypeBroad incumbent
Description

Established public-sector consulting firm with deep federal health, energy, and environmental practices serving HHS, DoD, DOE, and other civilian agencies. Overlaps with Everglade on proposal support and program execution, though within a much broader portfolio.

TypeDirect peer
Description

Federal management and technology consulting firm serving federal agencies and the contractors/innovators that serve them. Comparable scale and business model to Everglade, with overlap on grants, program management, and federal acquisition compliance.

TypeBroad incumbent
Description

Federal lobbying, funding, and appropriations advisory firm supporting life sciences, technology, and defense clients in Washington, DC. Comparable target market (federal funding seekers) and DC-centric relationship model, though with a stronger lobbying/appropriations focus.

TypeBroad incumbent
Description

Top-tier federal consulting firm with a large defense, health, and civil portfolio serving DoD, HHS, intelligence, and civilian agencies. Competes for federal R&D advisory mandates, though typically at much larger engagement scale than Everglade.

TypeBroad incumbent
Description

Large management consulting firm with a substantial public sector and federal health practice (formerly PwC's public sector business). Overlaps with Everglade on HHS, DoD, and civilian advisory work but at vastly greater scale and broader scope.

7Catalyst Partners
TypeDirect peer
Description

Federal funding and government affairs consulting firm supporting clients pursuing grants and contracts across civilian and defense agencies. Comparable model: end-to-end proposal, award, and compliance support for federal R&D clients.

TypeBroad incumbent
Description

Major federal contractor with Health & Civil and Defense solutions serving HHS, DoD, DOE, and intelligence agencies. Competes with Everglade in federal health and life sciences program support, typically as a large-systems integrator rather than a niche advisor.

TypeDirect peer
Description

Specialized federal funding and grants advisory firm serving research institutions and life sciences innovators. Closely comparable niche: helps clients identify, pursue, and manage federal R&D awards with a similar relationship-driven, lifecycle-based service model.

TypeBroad incumbent
Description

Federal management and program execution consultancy supporting DoD, HHS, and civilian agencies. Comparable on program management, compliance, and post-award execution services delivered to federal R&D clients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles21 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Everglade Consulting

Federal Funding Advisory Serviceseverglade.com

EverGlade Consulting is a privately held U.S. advisory firm that helps life sciences and technology innovators secure and execute non-dilutive federal funding across HHS, DoD, civilian science agencies, DOE, and DFC, offering a full Strategize-to-Execute lifecycle service.

What Everglade Consulting does

Everglade Consulting (legal entity: EverGlade Consulting, LLC) is a privately held, U.S.-headquartered advisory firm that helps life sciences and technology innovators navigate the federal funding ecosystem from opportunity identification through post-award program closeout. Founded in 2020 and operating from Houston, TX and Washington, DC, the firm is organized around a four-stage lifecycle — Strategize, Propose, Negotiate, Execute — delivered through dedicated practices across HHS (BARDA, ARPA-H, NIAID, ASPR IBx), DoD (DARPA, DTRA, DIU, JPEO-CBRND consortium vehicles MTEC, MCDC, CWMD), civilian energy agencies (DOE Loan Programs Office, ARPA-E, EERE), and the International Development Finance Corporation. The firm has stated it has helped clients secure more than $3 billion in non-dilutive federal funding across agencies, with named engagements including up to $45M for GeoVax Labs (BARDA, 2024) and up to $18.3M for Landmark Bio (ARPA-H, 2026).

The firm's underlying capability stack rests on regulatory fluency in FAR, DFARS, CAS, and federal acquisition mechanisms (BAAs, RFPs, OTAs, cooperative agreements), combined with a senior bench of PhD scientists, PMP-certified program managers, MBAs, and former government COTRs/Auditors. Its proprietary program infrastructure comprises standardized tools, templates, and processes built through repeated R&D program execution, packaged into a repeatable methodology marketed as "Boost Your Success Rate." Distribution is sales-led and direct: the firm runs a content-marketing engine (blog, solicitation alerts, LinkedIn, YouTube, PR Newswire distributions) feeding direct enterprise consultations with biotech, medtech, pharma, autonomous tech, AI/cybersecurity, energy, and academic research clients.

Everglade is bootstrapped and founder-owned (co-founders Eric Jia-Sobota and Jerry Jia-Sobota), with no disclosed venture or private equity rounds. Giacomo Apadula, Jr. was appointed CEO effective October 6, 2025, and Dr. Patrick Sims joined as Managing Consultant in April 2026, signaling a transition from founder-led to professionally-managed scale-up. Revenue is generated through customized, quote-based professional services engagements, typically structured as multi-year contracts tied to pursuit-and-execution milestones.

Everglade Consulting firmographics

Firmographics
Name
Everglade Consulting
Legal name
EverGlade Consulting, LLC
Website
https://everglade.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
EverGlade Consulting is a privately held U.S. advisory firm that helps life sciences and technology innovators secure and execute non-dilutive federal funding across HHS, DoD, civilian science agencies, DOE, and DFC, offering a full Strategize-to-Execute lifecycle service.
Ownership category
akta.pro rank

Everglade Consulting industry classification

Industry
Product category
Federal Funding Advisory Services
NAICS
Management Consulting Services (54161), Management, Scientific, and Technical Consulting Services (5416)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPAHACAJ
Risk, Compliance & Internal Controls Consulting
SECONDARYBPAHACAM
Innovation, Product & R&D Consulting

Keywords

  • Federal funding advisory
  • Life sciences consulting
  • Government grant services
  • Technology funding consulting
  • Proposal development services

Where Everglade Consulting is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Everglade Consulting business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Federal Funding Advisory Services: Professional consulting services for the full federal funding lifecycle including strategy, proposal pursuit, contract negotiations, and post-award execution and compliance support. Services are tailored to each client engagement with custom pricing based on scope and complexity.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom consulting engagements

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Everglade Consulting product offering

Product offering

Core offering

Everglade Consulting provides professional advisory services that guide life sciences and technology innovators through the full federal funding lifecycle, including strategy, proposal pursuit, contract negotiations, and post-award execution and compliance support. The firm secures and executes high-risk, high-impact R&D funding programs across HHS, DoD, and civilian science and technology agencies. Service offerings are organized as Strategize, Propose, Negotiate, and Execute, with specialized advisory for agencies such as BARDA, ARPA-H, NIAID, DARPA, DTRA, DIU, DOE, and DFC.

Product overview

Everglade Consulting is a national advisory firm that provides strategic consulting services to help life sciences and technology innovators navigate the federal funding ecosystem. The company offers a comprehensive suite of advisory services organized around the federal funding lifecycle: Strategize, Propose, Negotiate, and Execute. Their service offerings are specialized by funding domain, including BARDA Funding Advisory, ARPA-H Funding Advisory, NIAID Funding Advisory, CPE CBRND Funding Advisory, DoD Agencies & Offices Advisory, Autonomous Technology Funding Advisory, Energy Funding Advisory, and DFC Loan Advisory. The firm supports clients across HHS, DoD, and civilian science and technology agencies, helping secure non-dilutive funding for high-risk, high-impact R&D programs.

Differentiator

Problem solved

Functional benefit

Products and services

  • Strategize Services Federal funding pursuit strategy development including program fit validation, technical viability assessment, technology alignment to agency priorities, and ongoing federal landscape review, for organizations seeking non-dilutive R&D funding.
  • Propose Services Proposal development and submission support including TechWatch meetings, concept papers, white papers, solution summaries, full proposal development, statement of work, work breakdown structure, technical approach, integrated master schedule, budget design, and subcontractor management, for clients pursuing federal funding.
  • Negotiate Services Contract negotiation support including contract review and positioning, cost share and budget clarifications, response strategy development, and terms alignment and finalization, for clients negotiating federal awards.
  • Execute Services Post-award program execution support including program oversight, risk and performance management, subcontractor and procurement oversight, financial and contract compliance with USG audit support, and project closeout, for clients executing federal awards.
  • BARDA Funding Advisory Specialized advisory services for securing funding from the Biomedical Advanced Research and Development Authority (BARDA), supporting vaccine, therapeutic, and diagnostic development through BAAs, RFPs, and Other Transaction Agreements, for biotech and life sciences companies.
  • ARPA-H Funding Advisory Advisory services for securing funding from the Advanced Research Projects Agency for Health (ARPA-H), including support for Innovative Solutions Openings (ISOs), Mission Office ISOs, and targeted research initiatives, for health-focused research organizations.
  • NIAID Funding Advisory Advisory services for securing funding from the National Institute of Allergy and Infectious Diseases (NIAID), including grants, contracts, and cooperative agreements for infectious and immunologic disease research, for academic and biotech clients.
  • JPEO CBRND Funding Advisory Advisory services for Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense funding opportunities, including MTEC, MCDC, and CWMD consortium programs, for biodefense and CBRN defense clients.
  • DoD Agencies & Offices Funding Advisory Advisory services for Department of Defense funding including DARPA (synthetic biology, trauma care, biosciences), DTRA (biodefense technologies), DPA Title III (domestic production capabilities), and DIU (commercial technology adoption), for defense-oriented biotech and technology clients.
  • Autonomous Technology Funding Advisory Advisory services for autonomous technology and AI funding including defense and security innovation (DARPA, DIU, JAIC), artificial intelligence R&D (NSF AI Institutes, DOE AI Grants), emerging technologies, cybersecurity, and unmanned systems, for AI, cybersecurity, and autonomous systems companies.
  • Energy Funding Advisory Advisory services for energy innovation funding including DOE Loan Programs Office support, ARPA-E (energy technology RDT&E), EERE (energy efficiency and renewable energy), and Infrastructure Investment and Jobs Act programs, for clean energy and sustainable technology organizations.
  • DFC Loan Advisory Advisory services for International Development Finance Corporation (DFC) loan programs supporting private sector investment in emerging markets, including healthcare, biotechnology, technology, advanced manufacturing, defense, infrastructure, and renewable energy sectors, for companies pursuing international expansion financing.

Quantifiable outcome

  • $3B+ in non-dilutive federal funding secured across agencies
  • +2 more outcomes

Companies that use Everglade Consulting

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Everglade Consulting technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Everglade Consulting partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Landmark BiocoreStrategic or Co-development Partner · 21 April 2026Everglade guided Landmark Bio through the federal funding process including negotiations, project structuring, and financial planning to secure up to $18.3 million from ARPA-H's TRANSFORM-EV program for extracellular vesicle manufacturing.
  • GeoVax LabscoreStrategic or Co-development Partner · 28 August 2024Everglade supported GeoVax Labs in securing up to $45 million in BARDA funding for next-generation COVID-19 vaccine development. The partnership included manufacturing support and Phase 2b clinical trial funding.
  • IDBiologicscoreStrategic or Co-development PartnerEverglade manages technical and financial reporting processes for IDBiologics' federal award, allowing the client to focus on scientific research and discovery.
  • AllucentminorStrategic or Co-development PartnerSupporting partner in GeoVax COVID-19 vaccine development with overall clinical evaluation value up to $388 million including additional support from Allucent.
  • Medical Technology Enterprise Consortium (MTEC)minorOthersEverglade supports clients pursuing funding through MTEC, which focuses on accelerating development of medical technologies for military and civilian use in support of DTRA.
  • Rapid Response Partnership Vehicle (RRPV) ConsortiumminorOthersJoint initiative with BARDA to promote R&D in response to pandemics or public health emergencies. Everglade helps clients access funding through this consortium vehicle.
  • Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C)minorOthersConsortium advancing biomanufacturing innovations to enhance production efficiency and scalability, with Everglade supporting client participation.
  • Medical CBRN Defense Consortium (MCDC)minorOthersConsortium advancing development efforts to support DoD's medical, pharmaceutical, and diagnostic requirements related to CBRN defense.
  • Countering Weapons of Mass Destruction Consortium (CWMD)minorOthersConsortium supporting DoD's ability to detect, prevent, and protect against WMD threats, with Everglade assisting client engagement.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Everglade Consulting competitors and assessment

Company assessment

Direct peers

  • The Conafay Group: Life sciences-focused federal funding and SBIR/STTR advisory firm supporting biotech and medtech companies pursuing BARDA, NIH, and DoD awards. Direct head-to-head competitor in the federal grant advisory niche Everglade serves.
  • Attain Partners: Federal management and technology consulting firm serving federal agencies and the contractors/innovators that serve them. Comparable scale and business model to Everglade, with overlap on grants, program management, and federal acquisition compliance.
  • Catalyst Partners: Federal funding and government affairs consulting firm supporting clients pursuing grants and contracts across civilian and defense agencies. Comparable model: end-to-end proposal, award, and compliance support for federal R&D clients.
  • Federal Science Partners: Specialized federal funding and grants advisory firm serving research institutions and life sciences innovators. Closely comparable niche: helps clients identify, pursue, and manage federal R&D awards with a similar relationship-driven, lifecycle-based service model.

Broad incumbents

  • ICF International: Established public-sector consulting firm with deep federal health, energy, and environmental practices serving HHS, DoD, DOE, and other civilian agencies. Overlaps with Everglade on proposal support and program execution, though within a much broader portfolio.
  • Cornerstone Government Affairs: Federal lobbying, funding, and appropriations advisory firm supporting life sciences, technology, and defense clients in Washington, DC. Comparable target market (federal funding seekers) and DC-centric relationship model, though with a stronger lobbying/appropriations focus.
  • Booz Allen Hamilton: Top-tier federal consulting firm with a large defense, health, and civil portfolio serving DoD, HHS, intelligence, and civilian agencies. Competes for federal R&D advisory mandates, though typically at much larger engagement scale than Everglade.
  • Guidehouse (Public Sector): Large management consulting firm with a substantial public sector and federal health practice (formerly PwC's public sector business). Overlaps with Everglade on HHS, DoD, and civilian advisory work but at vastly greater scale and broader scope.
  • Leidos: Major federal contractor with Health & Civil and Defense solutions serving HHS, DoD, DOE, and intelligence agencies. Competes with Everglade in federal health and life sciences program support, typically as a large-systems integrator rather than a niche advisor.
  • CALIBRE Systems: Federal management and program execution consultancy supporting DoD, HHS, and civilian agencies. Comparable on program management, compliance, and post-award execution services delivered to federal R&D clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Everglade Consulting social profiles

Digital presence

Everglade Consulting financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Everglade Consulting leadership team

Management profile

Number of profiles

Profiles21 records

Everglade Consulting funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Everglade Consulting M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Everglade Consulting

What does Everglade Consulting do?

Everglade Consulting provides professional advisory services that guide life sciences and technology innovators through the full federal funding lifecycle, including strategy, proposal pursuit, contract negotiations, and post-award execution and compliance support. The firm secures and executes high-risk, high-impact R&D funding programs across HHS, DoD, and civilian science and technology agencies. Service offerings are organized as Strategize, Propose, Negotiate, and Execute, with specialized advisory for agencies such as BARDA, ARPA-H, NIAID, DARPA, DTRA, DIU, DOE, and DFC.

Is Everglade Consulting a public or private company?

Everglade Consulting is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Everglade Consulting founded?

Everglade Consulting was founded in 2020. It employs 11 to 50 people.

Where is Everglade Consulting based?

Everglade Consulting is headquartered in Houston, United States, in the North America region.

How does Everglade Consulting make money?

One revenue line is on record: federal Funding Advisory Services.

Who are Everglade Consulting's main competitors?

Direct peers on record are The Conafay Group, Attain Partners, Catalyst Partners and Federal Science Partners. Broad incumbents are ICF International, Cornerstone Government Affairs, Booz Allen Hamilton, Guidehouse (Public Sector), Leidos and CALIBRE Systems.

Does Everglade Consulting have an API?

No public API is recorded for Everglade Consulting.

What industry is Everglade Consulting in?

Everglade Consulting's product category is Federal Funding Advisory Services. Its primary akta.pro industry code is BPAHACAJ, Risk, Compliance & Internal Controls Consulting, with a secondary code of BPAHACAM, Innovation, Product & R&D Consulting. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizEverGlade's Stephen Richardson and Laura Grace Elected to BioMaP and MCDC Leadership PositionsStephen Richardson and Laura Grace of EverGlade were elected to leadership positions in BioMaP and MCDC. Richardson will chair Voice of Membership on BioMaP's executive steering committee, while Grace will represent small businesses on MCDC's executive committee. The roles aim to strengthen industry-government collaboration on health security preparedness.PR NewswireEverGlade's Stephen Richardson and Laura (Powell) Grace Elected to BioMaP and MCDC Leadership RolesEverGlade announced that Stephen Richardson and Laura Grace were elected to leadership roles with two health security consortia. Richardson will chair BioMaP's executive steering committee, and Grace will serve as a small business representative on MCDC's executive committee. The appointments aim to strengthen industry-government collaboration and improve program outcomes.PR NewswireEVERGLADE WELCOMES FORMER ARPA-H SCIENTIFIC ADVISOR KATE TEFFER TO EXPAND FEDERAL HEALTH RESEARCH CAPABILITIESKate Teffer, PhD, joined EverGlade as Senior Technical Strategist, bringing over a decade of federal biomedical R&D advisory experience. She previously served as a scientific advisor to ARPA-H's Health Science Futures Mission Office, co-authoring its original announcements. The firm has secured over $3 billion in funding and manages 50 programs.PR NewswireEverGlade Consulting Enters New Chapter of Growth: Welcomes Giacomo Apadula as Chief Executive OfficerEverGlade Consulting appointed Giacomo Apadula as CEO, effective October 6, 2025. He brings over two decades of experience in government contracting, strategy, and federal compliance. The appointment aims to guide the firm's growth and innovation.PR NewswireEverGlade Consulting Helps Cirsium Secure up to $61 Million in ARPA-H FundingEverGlade Consulting helped Cirsium Biosciences secure up to $61 million in ARPA-H funding to develop a plant-based manufacturing platform for viral vector gene therapies. The funding aims to reduce production costs and time, with Cirsium's current process already cutting lead times by up to 80%.YahooEverGlade Consulting Helps Cirsium Secure up to $61 Million in ARPA-H FundingEverGlade Consulting helped Cirsium Biosciences secure up to $61 million in ARPA-H funding to develop a plant-based manufacturing platform for viral vector gene therapies. The funding aims to reduce production costs and time, with Cirsium's current process already cutting lead times by up to 80%.MorningstarEverGlade Consulting Funding Alert: Cancer Moonshot and the ARPA-H Cancer Funding LandscapeThe Biden-Harris administration's Cancer Moonshot initiative includes ARPA-H funding opportunities for cancer research, including the POSEIDON program for synthetic biology-based early detection tests. ARPA-H's ISO, PHO, and SSO offices are soliciting solution summaries due March 3, 2025, for cancer-focused projects.YahooEverGlade Consulting Funding Alert: Cancer Moonshot and the ARPA-H Cancer Funding LandscapeThe Biden-Harris administration's Cancer Moonshot initiative includes ARPA-H funding opportunities for cancer research, including the POSEIDON program for synthetic biology-based early detection tests. ARPA-H's ISO and PHO solicitations are open for cancer programs, with solution summaries due March 3, 2025.YahooEverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA FundingEverGlade Consulting helped GeoVax Labs secure up to $45 million in BARDA funding for its dual-antigen COVID-19 vaccine candidate GEO-CM04S1. The funding will support manufacturing and a 10,000-participant Phase 2b trial comparing the vaccine to an FDA-approved mRNA vaccine. Preparations are underway, with execution fully funded by BARDA.PR NewswireEverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA FundingEverGlade Consulting helped GeoVax Labs secure up to $45 million in BARDA funding for its dual-antigen COVID-19 vaccine candidate GEO-CM04S1. The funding will support manufacturing and a Phase 2b clinical trial, with a separate $343 million award to Allucent for the study, totaling up to $388 million.